Time Restricted Eating for Sleep Deprivation
(CRISP Trial)
Trial Summary
The trial allows the use of certain medications like birth control, second-generation antihistamines, antacids, and acne-related ointments. However, if you are taking medications for chronic conditions like high blood pressure, high cholesterol, or diabetes, you may not be eligible to participate. It's best to discuss your specific medications with the study team.
Research suggests that Time Restricted Eating (TRE) may improve sleep and health-related quality of life, as well as help with weight loss and cardiovascular health. While these studies focus on other conditions, they indicate potential benefits of TRE that could also positively impact sleep.
12345Time-restricted eating (TRE) has been studied in humans and is generally considered safe, with research showing it can lead to weight loss and metabolic benefits without altering diet quality. However, individual responses can vary, and it's important to consult with a healthcare provider before starting any new dietary regimen.
12467Time-restricted eating (TRE) is unique because it focuses on limiting the hours during which you eat each day, rather than what you eat. This approach is different from other treatments for sleep deprivation, which might focus on sleep hygiene or medication, as it potentially influences sleep patterns by regulating eating times.
14689Eligibility Criteria
This trial is for adults aged 18-45 with a BMI of 25-35 who usually sleep less than 6.5 hours and eat over a span of more than 14 hours per day. They should not have chronic health issues like hypertension or diabetes, but those with prehypertension or prediabetes may join if they agree to use birth control (if applicable) and can follow the study's eating schedule.Inclusion Criteria
Exclusion Criteria
Trial Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are randomized to either time restricted eating (8h/day) or habitual eating duration (>14h/day) for 4 weeks
Follow-up
Participants are monitored for changes in cardiovascular and metabolic markers after the intervention